3 results
Approved WMOPending
To establish the safety, tolerability, and early efficacy of multiple doses of hLF1-11 given once daily for 14 days.
Approved WMOPending
Primary Objective:To evaluate the efficacy of ELX/TEZ/IVA in subjects 6 through 11 years of age with CF, heterozygous for F508del and a MF mutation (F/MF)Secondary Objectives:• To evaluate the PD of ELX/TEZ/IVA• To evaluate the safety of ELX/TEZ/IVA
Approved WMOPending
The aim of this study is to investigate if non-invasive HD-tDCS brain stimulation can be used to stimulate thought suppression in healthy individuals (experiment 1) and in individuals with heightened levels of anxiety (experiment 2).